Calendrier des promotions National Research Corporation
Calendrier avancé
Graphique simple
À propos de l'entreprise
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. plus de détailsIPO date | 1997-10-10 |
---|---|
ISIN | US6373722023 |
Industry | Health Care Providers & Services |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 2.04 |
Дивиденд ао | 0.24 |
Сайт | https://www.nrchealth.com |
Цена ао | 31.06 |
Changement de prix par jour: | -2.84% (17.94) |
---|---|
Changement de prix par semaine: | +1.51% (17.17) |
Changement de prix par mois: | -10.52% (19.48) |
Changement de prix sur 3 mois: | -22.15% (22.39) |
Changement de prix sur six mois: | -23.85% (22.89) |
Changement de prix par an: | -55.94% (39.56) |
Evolution du prix sur 3 ans: | -57.17% (40.7) |
Evolution du prix sur 5 ans: | -72.68% (63.8) |
Evolution des prix sur 10 ans: | 0% (17.43) |
Evolution des prix depuis le début de l'année: | -10.52% (19.48) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Dividende, % | Dividende | Sur la base des résultats de la période | Acheter avant | Date de clôture du registre | Paiement avant |
---|---|---|---|---|---|
0.39% | 0.12 | II кв. 2024 | 25.09.2024 | 27.09.2024 | 14.10.2024 |
0.3% | 0.12 | IV кв. 2023 | 25.03.2024 | 27.03.2024 | 11.04.2024 |
0.29% | 0.12 | III кв. 2023 | 26.12.2023 | 28.12.2023 | 12.01.2024 |
Établissements | Volume | Partager, % |
---|---|---|
Kayne Anderson Rudnick Investment Management LLC | 2881464 | 12.08 |
Blackrock Inc. | 1065585 | 4.47 |
Morgan Stanley | 943710 | 3.96 |
Vanguard Group Inc | 934644 | 3.92 |
Conestoga Capital Advisors, LLC | 780806 | 3.27 |
Dimensional Fund Advisors LP | 636402 | 2.67 |
QV Investors Inc. | 395102 | 1.66 |
Renaissance Technologies, LLC | 373584 | 1.57 |
Geode Capital Management, LLC | 356305 | 1.49 |
State Street Corporation | 342475 | 1.44 |
ETF | Partager, % | Rentabilité pour l'année, % | Dividendes, % |
---|---|---|---|
iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.06502 | 18.2 | 1.66828 |
iShares Russell 2000 Growth ETF | 0.02498 | 38.04 | 0.6026 |
iShares Morningstar Small-Cap Growth ETF | 0.01365 | 33.63 | 0.72598 |
iShares Morningstar Small-Cap Growth ETF | 0.01365 | 587.89 | 0.72598 |
iShares Morningstar Small-Cap ETF | 0.00669 | 30.1 | 1.60498 |
iShares Morningstar Small-Cap ETF | 0.00669 | 391.25 | 1.60498 |
iShares Russell 3000 ETF | 0.00055 | 24.83 | 1.43482 |
SPDR Portfolio Europe ETF | 0.00011 | 8.94 | 3.66537 |
Dimensional International Core Equity 2 ETF | 0.00006 | 6.52 | 3.69996 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Mr. Michael D. Hays | Founder, CEO, President & Director | 131.11k | 1955 (70 années) |
Ms. Helen L. Hrdy | Chief Customer Officer | 291.51k | 1965 (60 années) |
Mr. Jon Boumstein | Chief Delivery Officer | N/A | |
Megan Charko | Senior Manager of Content Marketing | N/A | |
Mr. Christophe Louvion | Chief Product & Technology Officer | N/A | 1973 (52 année) |
Mr. Andy Monnich | Chief Corporate Development Officer | N/A | 1976 (49 années) |
Mr. Jason Hahn | Chief Revenue Officer | N/A | 1972 (53 année) |
Ms. Linda Stacy | Secretary | N/A | |
Ms. Vinitha Ramnathan | Chief Product Officer |
Adresse: United States, Lincoln. NE, 1245 Q Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.nrchealth.com
Site web: https://www.nrchealth.com